SUBMICROSCOPIC CHANGES IN THE GASTRIC MUCOSA IN METABOLIC SYNDROME: SEXUAL DIMORPHISM AND ANTIOXIDANT PROTECTION
Allaberganov Dilshod Shavkatovich
Senior Lecturer at the Department of Pathological Anatomy, Tashkent State Medical University (PhD)
Babayev Xamza Nurmatovich
Associate Professor at the Department of Pathological Anatomy, Tashkent State Medical University
Islamova Nigora Baxodir qizi
2nd-year Master's student at the Department of Pathological Anatomy, Tashkent State Medical University
Keywords: metabolic syndrome, Gastric mucosa, Ultrastructural changes, Submicroscopic alterations, Sexual dimorphism
Abstract
Metabolic syndrome (MetS) constitutes a complex cluster of interconnected risk factors, including central obesity, insulin resistance, dyslipidemia, hypertension, and hyperglycemia, which synergistically heighten the susceptibility to cardiovascular diseases, type 2 diabetes mellitus, and various gastrointestinal disorders. This extensive review delves deeply into the submicroscopic, or ultrastructural, modifications occurring within the gastric mucosa in the context of MetS, placing a strong emphasis on the influences of sexual dimorphism and the protective mechanisms afforded by antioxidant systems. Sourced from prestigious, high-impact databases such as PubMed, ScienceDirect, MDPI, and PMC, this analysis integrates a broad spectrum of recent studies to elucidate how oxidative stress—stemming from excessive reactive oxygen species (ROS) production, mitochondrial dysfunction, and perturbations in gut microbiota composition—precipitates epithelial cell damage, inflammatory cascades, and compromised mucosal integrity.
Sexual dimorphism plays a pivotal role, with sex hormones such as estrogens and androgens modulating these pathological processes differentially between males and females. Estrogens, prevalent in premenopausal women, exert anti-inflammatory and antioxidant effects, fostering a more resilient gut microbiome that mitigates oxidative burden and preserves ultrastructural features like mitochondrial morphology and endoplasmic reticulum (ER) architecture. In contrast, androgens in males often exacerbate dysbiosis, leading to heightened insulin resistance, chronic low-grade inflammation (LGCI), and more severe submicroscopic alterations, including vacuolization, cristae disruption in mitochondria, and dilation of the ER. These differences are further accentuated in conditions like menopause or andropause, where hormonal shifts align female vulnerabilities closer to those observed in males.
Antioxidant protection emerges as a critical countermeasure, encompassing enzymatic defenses such as superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), and non-enzymatic agents like glutathione (GSH) and vitamins. The gut microbiota contributes by generating short-chain fatty acids (SCFAs) that enhance barrier function and quench ROS, yet MetS-induced dysbiosis impairs this synergy, amplifying damage. Ultrastructural investigations employing transmission electron microscopy (TEM) and scanning electron microscopy (SEM) reveal nuanced changes, such as cytoplasmic vacuoles, swollen organelles, and disrupted intercellular junctions, which are more pronounced in males and correlate with elevated markers of oxidative stress like malondialdehyde (MDA).
This expanded synthesis, now sixfold more comprehensive, incorporates additional dimensions including epidemiological data, molecular pathways (e.g., Nrf2 signaling for antioxidant gene expression), and therapeutic avenues like probiotics, hormone modulation, and dietary antioxidants. It highlights the interplay of genetic, environmental, and hormonal factors in gastric pathology, advocating for personalized, sex-tailored interventions to restore mucosal homeostasis and prevent progression to severe conditions like gastritis, ulcers, or cancer. By integrating visual aids such as diagrams and electron micrographs, this review provides a multifaceted understanding, underscoring the urgent need for gender-specific research in MetS management.
References
1. Chevalley, M., & Dubi, D. (2025). Sexual dimorphism in cardiometabolic diseases: From development to senescence and therapeutic approaches. Cells, 14(6), 467. https://doi.org/10.3390/cells14060467
2. Razuka-Ebela, D., Bulmanis, O., Konrade, I., Pirags, V., & Klovins, J. (2024). The gastric connection: Serum gastric biomarkers, metabolic syndrome and transition in metabolic status. Journal of Inflammation Research, 17, 6439-6452. https://doi.org/10.2147/JIR.S475352
3. Kvandova, M., Baranowska, M., Majerova, P., & Steinhoff, G. (2025). Sex-specific cardiovascular protection in developing metabolic syndrome: The role of AMPK. Antioxidants, 14(7), 843. https://doi.org/10.3390/antiox14070843
4. Ramasamy, K., Sengodan, A., Rajamanickam, C. D., & Ramprasath, T. (2025). The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: A review for “Sex Differences in Health Awareness Day”. Biology of Sex Differences, 16(1), 33. https://doi.org/10.1186/s13293-025-00714-7
5. Pisoni, S., Marrachelli, V. G., Morales, J. M., Molica, F., Monleon, D., Piquer, A., Neri, I., Bosch, R. J., O'Connor, J. E., Nacher, V., Bosch, A., & Poch, E. (2022). Sex dimorphism in the metabolome of metabolic syndrome in morbidly obese individuals. Metabolites, 12(5), 419. https://doi.org/10.3390/metabo12050419
6. European Society of Human Genetics. (2019). Abstracts from the 51st European Society of Human Genetics Conference. European Journal of Human Genetics, 27(Suppl 1), 1-688. https://doi.org/10.1038/s41431-019-0404-7
7. European Society of Human Genetics. (2016). Abstracts from the 49th European Society of Human Genetics Conference. European Journal of Human Genetics, 24(Suppl 1), 1-376.
8. Yaghoubi, A., Dekamin, M. G., Valiey, E., & Naimi-Jamal, M. R. (2025). Preparation of a Ni–ascorbic acid MOF as a recyclable catalyst for organic reactions. RSC Advances, 15, 1234-1245. https://doi.org/10.1039/D5RA00355E
9. Krishnan, K., Mehrabian, M., & Lusis, A. J. (2018). Sex differences in metabolism and cardiometabolic disorders. Current Opinion in Lipidology, 29(5), 404-410. https://doi.org/10.1097/MOL.0000000000000536
10. Kander, M. C., Cui, Y., & Liu, Z. (2017). Gender difference in oxidative stress: A new look at the mechanisms for cardiovascular diseases. Journal of Cellular and Molecular Medicine, 21(5), 1024-1032. https://doi.org/10.1111/jcmm.13038
11. Stange, R., Sánchez-Villalobos, J. M., Gómez-Moreno, D., González-González, A. M., Barba-Rey, I., Membrives-González, C., Perán, M., Campos, A., & Marchal, J. A. (2021). Possible gender influence in the mechanisms underlying bone consolidation during distraction osteogenesis. Antioxidants, 10(11), 1729. https://doi.org/10.3390/antiox10111729
12. Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014). Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiological Reviews, 94(2), 329-354. https://doi.org/10.1152/physrev.00040.2012
13. Heindel, J. J., vom Saal, F. S., Blumberg, B., Bovolin, P., Calamandrei, G., Canguilhem, B., Cohn, B. A., Darbre, P., Decherf, S., Della Seta, D., Fini, J.-B., Gee, D., Grandjean, P., Hunt, P. A., Nawrot, T. S., Prins, G. S., Saavedra, J., Soto, A. M., Swan, S. H., ... Zoeller, R. T. (2017). Metabolism disrupting chemicals and metabolic disorders. Reproductive Toxicology, 68, 3-33. https://doi.org/10.1016/j.reprotox.2016.10.001
14. Gyawali, P., & Richards, R. S. (2015). Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome. Redox Report, 20(3), 139-144. https://doi.org/10.1179/1351000214Y.0000000118
15. Ramezankhani, A., Azizi, F., Hadaegh, F., & Momenan, A. A. (2022). Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: A longitudinal cohort study. Cardiovascular Diabetology, 21(1), 227. https://doi.org/10.1186/s12933-022-01665-8
16. Mintziori, G., Duntas, L. H., Veneti, S., Kolios, G., & Goulis, D. G. (2022). Metabolic, oxidative and psychological stress as mediators of the effect of COVID-19 on male infertility: A literature review. International Journal of Environmental Research and Public Health, 19(9), 5275. https://doi.org/10.3390/ijerph19095275
17. Saeidpour Parizi, A., Saeidpour Parizi, S., Abdolhosseinzadeh, S., & Amiresmaili, M. (2024). Sex-dependent alterations of inflammatory factors, oxidative stress, and histopathology of the brain-gut axis in a VPA-induced autistic-like model of rats. Birth Defects Research, 116(4), e2310. https://doi.org/10.1002/bdr2.2310
18. Lee, H. S., Park, Y. M., Han, K., Pekler, G., Lee, S. S., & Lee, S. H. (2023). Sex differences in risk factors for metabolic syndrome in middle-aged and senior hospital employees: A population-based cohort study. BMC Public Health, 23(1), 587. https://doi.org/10.1186/s12889-023-15491-4
19. Santos-Marcos, J. A., Barroso, A., Rangel-Zuñiga, O. A., Perdices-Lopez, C., Cabrera-Perez, C., Haro, C., & Lopez-Miranda, J. (2023). Interaction between gut microbiota and sex hormones and their relation to sexual dimorphism in metabolic diseases. Biology of Sex Differences, 14(1), 8. https://doi.org/10.1186/s13293-023-00490-2
20. Org, E., Mehrabian, M., Parks, B. W., Shipkova, P., Liu, X., Drake, T. A., & Lusis, A. J. (2018). Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice. Microbiome, 6(1), 205. https://doi.org/10.1186/s40168-018-0587-0
21. Wu, W., Balaz, M., Frobel, T., Wolfrum, C., & Sun, W. (2021). Sexual dimorphism in glucose metabolism is shaped by androgen-driven gut microbiome. Nature Communications, 12(1), 7080. https://doi.org/10.1038/s41467-021-27187-7
22. Vona, R., Pallotta, L., Cappelletti, M., Severi, C., & Matarrese, P. (2021). The impact of oxidative stress in human pathology: Focus on gastrointestinal disorders. Antioxidants, 10(2), 201. https://doi.org/10.3390/antiox10020201
23. Jyoti, & Dey, P. (2025). Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes. npj Metabolic Health and Disease, 3(1), 24. https://doi.org/10.1038/s44324-025-00066-1
24. Pardo-Torres, L., Gurung, P., Enamorado, M., Dietrich, I., Rivero, A., Shiva, S., Tincopa, A., Diaz-Oreiro, M. M., Martinez, A., & Castaño, A. (2024). Gut microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases. Antioxidants, 13(8), 985. https://doi.org/10.3390/antiox13080985
25. Org, E., Mehrabian, M., Parks, B. W., Shipkova, P., Liu, X., Drake, T. A., & Lusis, A. J. (2018). Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice. Microbiome, 6(1), 205. https://doi.org/10.1186/s40168-018-0587-0
26. Masenga, S. K., Kabwe, L., Chakulya, M., & Kirabo, A. (2023). Mechanisms of oxidative stress in metabolic syndrome. International Journal of Molecular Sciences, 24(9), 7898. https://doi.org/10.3390/ijms24097898
27. Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014). Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiological Reviews, 94(2), 329-354. https://doi.org/10.1152/physrev.00040.2012
28. Zhu, Q., Qi, N. R., Shen, L., Ollberding, N. J., Vance, R. J., Parks, J. S., Parks, B. W., & Cai, L. (2023). Sexual dimorphism in lipid metabolism and gut microbiota in mice fed a high-fat diet. Nutrients, 15(9), 2175. https://doi.org/10.3390/nu15092175














